Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)
Others
Ratios

Bioadaptives (BDPT) Amortization - Intangibles (2021 - 2024)

Historic Amortization - Intangibles for Bioadaptives (BDPT) over the last 4 years, with Q2 2024 value amounting to $18000.0.

  • Bioadaptives' Amortization - Intangibles rose 255878.88% to $18000.0 in Q2 2024 from the same period last year, while for Mar 2025 it was $18000.0, marking a year-over-year decrease of 3887.12%. This contributed to the annual value of $19941.0 for FY2024, which is 2922.2% down from last year.
  • Per Bioadaptives' latest filing, its Amortization - Intangibles stood at $18000.0 for Q2 2024, which was up 255878.88% from $1941.0 recorded in Q1 2024.
  • Over the past 5 years, Bioadaptives' Amortization - Intangibles peaked at $44583.0 during Q3 2021, and registered a low of -$10815.0 during Q4 2023.
  • Over the past 4 years, Bioadaptives' median Amortization - Intangibles value was $18000.0 (recorded in 2024), while the average stood at $17090.7.
  • As far as peak fluctuations go, Bioadaptives' Amortization - Intangibles crashed by 168114.04% in 2023, and later surged by 255878.88% in 2024.
  • Bioadaptives' Amortization - Intangibles (Quarter) stood at $41708.0 in 2021, then crashed by 98.36% to $684.0 in 2022, then tumbled by 1681.14% to -$10815.0 in 2023, then surged by 266.44% to $18000.0 in 2024.
  • Its Amortization - Intangibles was $18000.0 in Q2 2024, compared to $1941.0 in Q1 2024 and -$10815.0 in Q4 2023.